Answers are grounded in this paper and cite their sources.
No AccessJournal of Urology1 Feb 1974Abnormalities of Cell-Mediated Immunocompetence in Genitourinary Cancer William J. Catalona, Paul B. Chretien, and Emile E. Trahan William J. CatalonaWilliam J. Catalona More articles by this author , Paul B. ChretienPaul B. Chretien More articles by this author , and Emile E. TrahanEmile E. Trahan More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)59935-8AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1974 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByEl-Mahrouky A, Dawson D, Paulson D and Sanfilippo F (2018) The Predictive Value of 2,-4, Dinitrochlorobenzene Skin Testing in Patients with Bilharzial Bladder CancerJournal of Urology, VOL. 129, NO. 3, (499-501), Online publication date: 1-Mar-1983.Morales A, Wilson J, Pater J and Loeb M (2018) Cytoreductive Surgery and Systemic Bacillus Calmette-Guerin Therapy in Metastatic Renal Cancer: A Phase II TrialJournal of Urology, VOL. 127, NO. 2, (230-235), Online publication date: 1-Feb-1982.Lang J, Oliveux A, Bigel P, Mayer S and Bollack C (2018) Evaluation of Peripheral Blood T Lymphocytes in Renal Adenocarcinoma before and after Surgical Removal of the TumorJournal of Urology, VOL. 125, NO. 4, (486-488), Online publication date: 1-Apr-1981. (2018) Editorial CommentJournal of Urology, VOL. 125, NO. 4, (488-489), Online publication date: 1-Apr-1981.Herr H (2018) Suppressor Cells in Immunodepressed Bladder and Prostate Cancer PatientsJournal of Urology, VOL. 123, NO. 5, (636-639), Online publication date: 1-May-1980.W.J.C. (2018) Editorial CommentJournal of Urology, VOL. 123, NO. 5, (639-639), Online publication date: 1-May-1980.Dekernion J, Ramming K and Gupta R (2018) The Detection and Clinical Significance of Antibodies to Tumor-Associated Antigens in Patients with Renal Cell CarcinomaJournal of Urology, VOL. 122, NO. 3, (300-305), Online publication date: 1-Sep-1979.Stefani S, Menon M, Canning J and Clark S (2018) Cell-mediated Immune Competence in Patients with Prostatic CarcinomaJournal of Urology, VOL. 120, NO. 4, (431-434), Online publication date: 1-Oct-1978. (2018) Editorial CommentJournal of Urology, VOL. 120, NO. 4, (434-434), Online publication date: 1-Oct-1978.Sufrin G, Tritsch G, Mittelman A and Murphy G (2018) Adenosine Deaminase Activity in Patients with Carcinoma of the BladderJournal of Urology, VOL. 119, NO. 3, (343-346), Online publication date: 1-Mar-1978.Guinan P, Mckiel C, Flanagan M, Bhatti R, Pessis D and Ablin R (2018) Cellular Immunity in Bladder Cancer PatientsJournal of Urology, VOL. 119, NO. 6, (747-749), Online publication date: 1-Jun-1978.Herr H (2018) Immunobiolqgy of Human Bladder CancerJournal of Urology, VOL. 115, NO. 2, (147-147), Online publication date: 1-Feb-1976.Herr H, Bean M and Whitmore W (2018) Prognostic Significance of Regional Lymph Node Histology in Cancer of the BladderJournal of Urology, VOL. 115, NO. 3, (264-267), Online publication date: 1-Mar-1976. (2018) CommentJournal of Urology, VOL. 115, NO. 3, (267-267), Online publication date: 1-Mar-1976.Brosman S, Hausman M and Shacks S (2018) Immunologic Alterations in Patients with Prostatic CarcinomaJournal of Urology, VOL. 113, NO. 6, (841-845), Online publication date: 1-Jun-1975.Huus J, Kursh E, Poor P and Persky L (2018) Delayed Cutaneous Hypersensitivity in Patients with Prostatic AdenocarcinomaJournal of Urology, VOL. 114, NO. 1, (86-87), Online publication date: 1-Jul-1975.Decenzo J, Allison R and Leadbetter G (2018) Skin Testing in Genitourinary Carcinoma: 2-Year FollowupJournal of Urology, VOL. 114, NO. 2, (271-273), Online publication date: 1-Aug-1975.Catalona W, Smolev J and Harty J (2018) Prognostic Value of Host Immunocompetence in Urologic Cancer PatientsJournal of Urology, VOL. 114, NO. 6, (922-926), Online publication date: 1-Dec-1975.Catalona W, Potvin C and Chretien P (2018) Effect of Radiation Therapy for Urologic Cancer on Circulating Thymus-Derived LymphocytesJournal of Urology, VOL. 112, NO. 2, (261-267), Online publication date: 1-Aug-1974.Catalona W, Tarpley J, Chretien P and Castle J (2018) Lymphocyte Stimulation in Urologic Cancer PatientsJournal of Urology, VOL. 112, NO. 3, (373-377), Online publication date: 1-Sep-1974.Catalona W, Potvin C and Chretien P (2018) T Lymphocytes in Bladder and Prostatic Cancer PatientsJournal of Urology, VOL. 112, NO. 3, (378-382), Online publication date: 1-Sep-1974. Volume 111Issue 2February 1974Page: 229-232 Advertisement Copyright & Permissions© 1974 by The American Urological Association Education and Research, Inc.MetricsAuthor Information William J. Catalona More articles by this author Paul B. Chretien More articles by this author Emile E. Trahan More articles by this author Expand All Advertisement PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Catàlona et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: